| Literature DB >> 24784055 |
Chen-wei Wei, Jinjun Xia, Michael Lombardo, Camilo Perez, Bastien Arnal, Kjersta Larson-Smith, Ivan Pelivanov, Thomas Matula, Lilo Pozzo, Matthew O'Donnell.
Abstract
Optically activated cavitation in a nanoemulsion contrast agent is proposed for therapeutic applications. With a 56°C boiling point perfluorohexane core and highly absorptive gold nanospheres at the oil-water interface, cavitation nuclei in the core can be efficiently induced with a laser fluence below medical safety limits (70 mJ/cm2 at 1064 nm). This agent is also sensitive to ultrasound (US) exposure and can induce inertial cavitation at a pressure within the medical diagnostic range. Images from a high-speed camera demonstrate bubble formation in these nanoemulsions. The potential of using this contrast agent for blood clot disruption is demonstrated in an in vitro study. The possibility of simultaneous laser and US excitation to reduce the cavitation threshold for therapeutic applications is also discussed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24784055 PMCID: PMC9008802 DOI: 10.1364/OL.39.002599
Source DB: PubMed Journal: Opt Lett ISSN: 0146-9592 Impact factor: 3.776